Developing new pharmacotherapeutic approaches to treating sickle-cell disease.

about

Developing new pharmacotherapeutic approaches to treating sickle-cell disease.

Item

http://www.wikidata.org/entity/Q50207951

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Developing new pharmacotherapeutic approaches to treating sickle-cell disease.

@en

Developing new pharmacotherapeutic approaches to treating sickle-cell disease.

@nl

type

Item

label

Developing new pharmacotherapeutic approaches to treating sickle-cell disease.

@en

Developing new pharmacotherapeutic approaches to treating sickle-cell disease.

@nl

prefLabel

Developing new pharmacotherapeutic approaches to treating sickle-cell disease.

@en

Developing new pharmacotherapeutic approaches to treating sickle-cell disease.

@nl

P1476

Developing new pharmacotherapeutic approaches to treating sickle-cell disease

@en

P2093

Marilyn J Telen

http://www.w3.org/2001/XMLSchema#string

P2860

Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders

MEK inhibitors, novel anti-adhesive molecules, reduce sickle red blood cell adhesion in vitro and in vivo, and vasoocclusion in vivo

The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia

Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction

Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia

Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm

Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.

Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease.

Intravenous immunoglobulins modulate neutrophil activation and vascular injury through FcγRIII and SHP-1.

A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease.

P304

239-247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/VOXS.12305

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marilyn J. Telen

P577

2016-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28484512

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

5418585

http://www.w3.org/2001/XMLSchema#string